Related Experiment Video
Updated: Jan 18, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration
David Granadier1,2, Kirsten Cooper3, Dante Acenas3,4
1Translational Science and Therapeutic Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, USA. dgranadi@fredhutch.org.
Interleukin-18 (IL-18) released after tissue damage impairs thymus regeneration by activating natural killer (NK) cells. Targeting IL-18 may enhance immune recovery and offer insights into cancer immunotherapy side effects.
Area of Science:
- Immunology
- Cell Biology
- Regenerative Medicine
Background:
- Interleukin-18 (IL-18) is a pro-inflammatory cytokine vital for antiviral immunity.
- IL-18 activates T helper 1 CD4+ T cells, cytotoxic CD8+ T cells, and natural killer (NK) cells.
- Thymic regeneration is essential for restoring immune competence after insults like stress, infection, or chemotherapy.
Purpose of the Study:
- To investigate the role of IL-18 in thymic regeneration following tissue damage.
- To elucidate the mechanism by which IL-18 affects thymic recovery.
- To explore IL-18 as a potential therapeutic target for boosting thymic function.
Main Methods:
- Analysis of mature IL-18 generation in the thymus after various forms of tissue damage.
- Investigation of caspase-1-mediated immunogenic cell death pathways.
- Assessment of IL-18-stimulated NK cell activity and their impact on thymic epithelial cells.
Main Results:
- Mature IL-18 is generated in the thymus following tissue damage via caspase-1-mediated cell death.
- IL-18-stimulated NK cells inhibit endogenous thymic regeneration.
- NK cells target thymic epithelial cells, disrupting thymus recovery and immune competence restoration.
Conclusions:
- A novel pathway regulating thymic regeneration involving IL-18 and NK cells has been identified.
- IL-18 inhibition could be a therapeutic strategy to promote thymic function and immune recovery.
- Findings provide insights into potential off-target effects of IL-18 in cancer immunotherapy.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

